LY354740, a potent group II metabotropic glutamate receptor agonist prevents lactate-induced panic-like response in panic-prone rats

Neuropharmacology

Volumn 39, Issue 7, 2000, Pages 1139-1146

  Shekhar, A ^a   Keim, S R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alprazolam; Anxiety; Dorsomedial nucleus; GABA; Glutamate; Hypothalamus; Social interaction; Stress

Indexed keywords

4 AMINOBUTYRIC ACID; ALLYLGLYCINE; ALPRAZOLAM; BICUCULLINE METHIODIDE; EGLUMETAD; GLUTAMIC ACID; LACTIC ACID; METABOTROPIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HYPOTHALAMUS; NONHUMAN; PANIC; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; STRESS; THALAMUS DORSOMEDIAL NUCLEUS;

ALLYLGLYCINE; ALPRAZOLAM; ANIMALS; BEHAVIOR, ANIMAL; BICYCLO COMPOUNDS; BLOOD PRESSURE; EXCITATORY AMINO ACID AGONISTS; GABA MODULATORS; GLUTAMATE DECARBOXYLASE; HEART RATE; HYPOTHALAMUS, MIDDLE; INFUSIONS, INTRA-ARTERIAL; INTERPERSONAL RELATIONS; LACTIC ACID; MALE; PANIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RESPIRATORY MECHANICS;

EID: 0034100686     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00215-4     Document Type: Article

References (29)

1. Battaglia G., Monn J.A., Schoepp D.D. In-vivo inhibition of veratradine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats. Neuroscience Letters. 229:1997;161-164.
2. Bostwick J.R., Le W.-D. A tyrosine hydroxylase assay in microwells using coupled nonenzymatic decarboxylation of DOPA. Analytical Biochemistry. 192:1991;125-130.
3. DiMicco J.A., Soltis R.P., Anderson J.J., Wible J.H. Jr. Hypothalamic mechanisms and the cardiovascular response to stress. Kunos G., Ciriello J. Central Neural Mechanisms in Cardiovascular Regulation. Vol. 2:1992;52-79 Birkhauser, Boston.
4. File S.E. The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. Journal of Neuroscience Methods. 2:1980;219-238.
5. Helton D.R., Tizzano J.P., Monn J.A., Schoepp D.D., Kallman M.J. LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats. Neuropharmacology. 36:1997;1511-1516.
6. Helton D.R., Tizzano J.P., Monn J.A., Schoepp D.D., Kallman M.J. Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. Journal of Pharmacology and Experimental Therapeutics. 284:1998;651-660.
7. Keim S.R., Shekhar A. Chronic GABA dysfunction in the dorsomedial hypothalamus (DMH) of rats results in a panic-prone state that is NMDA and not non-NMDA receptor mediated. Society of Neuroscience Abstracts. 24:1998;1674.
8. Liebowitz M.R., Gorman J.M., Fyer A., Dillon D., Levitt M., Klein D.F. Possible mechanisms for lactate's induction of panic. Americal Journal of Psychiatry. 143:1986;495-502.
9. Monn J.A., Valli M.J., Massey S.M., Wright R.A., Salhoff C.R., Johnson B.G., Howe T., Alt C.A., Rhodes G.A., Robey R.L., Griffey K.R., Tizzano J.P., Kallman M.J., Helton D.R., Schoepp D.D. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-di-carboxylate: a potent, selective, systemically active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. Journal of Medical Chemistry. 40:1997;528-537.
10. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 258:1992;597-603.
11. Onishi H., Shigemoto R., Nakanishi S., Mizuno N. Distribution for the mRNA for a metabotropic glutamate receptor (mGlu receptor3) in the rat brain: an in situ hybridization study. Journal of Comparative Neurology. 335:1993;252-266.
12. Orlowski M., Reingold D.F., Stanley M.E. D- and l-stereoisomers of allylglycine: convulsive action and inhibition of brain l-glutamate decarboxylase. Journal of Neurochemistry. 28:1977;349-353.
13. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. second ed:1986;Academic Press, New York.
14. Pin J.-P., Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34:1995;1-26.
15. Pitts F.N., McClure J.N. Lactate metabolism in anxiety neurosis. New England Journal of Medicine. 227:1967;1329-1336.
16. Price L.H., Goddard A.W., Barr L.C., Goodman W.K. Pharmacological challenges in anxiety disorders. Bloom F.E., Kupfer D.J. Psychpharmacology: The Fourth Generation of Progression. 1995;1311-1323 Raven Press, New York.
17. A receptors in the basolateral amygdala of rats regulate "anxiety" Pharmacology, Biochemistry and Behavior. 52:1995;701-706.
18. Schauffhauser H., Richards J.G., Cartmell J., Chaboz S., Kemp J.A., Klingschmidt A., Messer J., Stadler H., Woltering T., Mutel V. In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain. Molecular Pharmacology. 53:1998;228-233.
19. Schoepp D.D. Novel functions for subtypes of metabotropic glutamate receptors. Neurochemistry International. 24:1994;439-449.
20. Schoepp D.D., Conn P.J. Metabotropic glutamate receptors in brain function and pathology. Trends in Pharmacological Sciences. 14:1993;13-20.
21. Schoepp D.D., Johnson B.G., Wright R.A., Salhoff C.R., Mayne N.G., Wu S., Cockerham S.L., Burnett J.P., Belagaje R., Bleakman D., Monn J.A. LY374740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptor. Neuropharmacology. 36:1997;1-11.
22. Schoepp D.D., Johnson B.G., Wright R.A., Salhoff C.R., Monn J.A. Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist. Naunyn-Schmiedeberg's Archives of Pharmacology. 358:1998;175-180.
23. Shekhar A. GABA blockade in the region of the dorsomedial hypothalamus regulates "anxiety" in rats in the elevated plus-maze: I. behavioral measures. Brain Research. 627:1993;9-16.
24. Shekhar A. Effects of chronic treatment with imipramine and clonazepam in an animal model of panic disorder. Biological Psychiatry. 36:1994;748-758.
25. A receptors in the dorsomedial hypothalamus of rats regulate anxiety in the social interaction test. Pharmacology, Biochemistry and Behavior. 50:1995;253-258.
26. Shekhar A., Keim S.R., Simon J.R., McBride W.J. Physiological arousal elicited by sodium lactate infusion in rats with dorsomedial hypothalamic GABA dysfunction. Pharmacology, Biochemistry and Behavior. 55:1996;249-256.
27. Shekhar A., Keim S.R. The circumventricular organs form a potential neural pathway for lactate sensitivity: implications for panic disorder. Journal of Neuroscience. 17:1997;9726-9735.
28. Shekhar A., Keim S.R. Panic responses in rats with chronic GABA dysfunction in the dorsomedial hypothalamus (DMH) following i.v. infusions of yohimbine and fenfluramine. Society of Neuroscience Abstracts. 24:1998;1673.
29. A and excitatory amino acid receptors controlling heart rate in rats. Americal Journal of Physiology. 261:1991;R427-R433.